英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

Rigel    音标拼音: [r'ɑɪdʒəl]


安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Rigel Pharmaceuticals, Inc. (RIGL)
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
  • Pipeline :: Rigel Pharmaceuticals, Inc. (RIGL)
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
  • Products :: Rigel Pharmaceuticals, Inc. (RIGL)
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
  • Who We Are :: Rigel Pharmaceuticals, Inc. (RIGL)
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
  • Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and . . .
    These forward-looking statements include, without limitation, anticipated financial performance for 2026; anticipated timing and results from the clinical development of R289; Rigel's intention to fund existing and new clinical development programs while anticipating positive net income for 2026; and our general statements regarding anticipated
  • Rigel Reports Third Quarter 2025 Financial Results and Provides . . .
    Rigel does not undertake any obligation to update forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements
  • Management Team :: Rigel Pharmaceuticals, Inc. (RIGL)
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
  • Rigel Announces R289 Granted Fast Track Designation by the FDA for . . .
    SOUTH SAN FRANCISCO, Calif , Dec 2, 2024 PRNewswire -- Rigel Pharmaceuticals, Inc (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U S Food and Drug Administration (FDA) has granted Fast Track designation to R289 for the treatment of patients with previously-treated transfusion dependent lower-risk
  • Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and . . .
    Coupled with Rigel's commitment to financial discipline, for the first time we generated full-year net income of more than $17 million and increased our cash balances by more than $20 million," said Raul Rodriguez, Rigel's president and CEO
  • Events Presentations :: Rigel Pharmaceuticals, Inc. (RIGL)
    © 2026 Rigel Pharmaceuticals, Inc All Rights Reserved TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel





中文字典-英文字典  2005-2009